Alkaloid AD Skopje is a prominent pharmaceutical manufacturer and distributor headquartered in Skopje, North Macedonia, with over nine decades of experience since its founding in 1936. Operating as a joint stock company with a global workforce of over 3,000 employees, the group manages two primary profit centers: Pharmaceuticals and Chemicals, Cosmetics, and Botanicals. The company maintains a robust international presence with 22 subsidiaries and representative offices across Europe and the USA.
As a leading provider of generic drugs and value-added medicines, the company specializes in pharmaceutical manufacturing and quality control, including the development of liquid Omeprazole ready to use formulations for pediatric GERD treatment. Their extensive production capabilities include an annual capacity of 2 billion solid dose units, 200 million cephalosporin capsules, and 3.5 million bottles of oral suspension dry powder. Specialized processes include the manufacturing of semisynthetic cephalosporins in a dedicated factory, production of non-sterile liquids, and manufacturing of haemodialysis solutions. The company is also a key supplier of API-Small Molecules, specifically Codeine Phosphate, and niche market morphine-based products.
Alkaloid AD Skopje offers comprehensive OEM and contract manufacturing services, supported by advanced technical infrastructure such as SAP S/4 HANA, AlkaT&T Track & Trace systems, and AlkaCDS Chromatography Data System management. Their facilities are certified to the highest international standards, including European Good Manufacturing Practice (EU-GMP), US Food and Drug Administration (FDA) regulations, ISO 9001, and CE Marking for X-ray films and haemodialysis solutions. Beyond pharmaceuticals, the company excels in the processing of botanical raw materials and the production of specialized cosmetic and chemical products.
OEM manufacturerOffers OEM services for customized brand manufacturing.
ODM manufacturerProvides ODM design and manufacturing solutions.
Own brandOwns and operates its own brands and manufacturing facilities.
High capacity factoryCan handle large-scale or bulk production orders.
Contact
No contact yet
Customers
ALKALOID
389 shipments
************
No shipments
***********
No shipments
***********
No shipments
****
No shipments
Unlock all 24 customers
Unlock
Certifications
GMP
3
Good Manufacturing Practice
FDA
1
FDA Compliance
ISO 9001
1
International Organization for Standardization 9001
CE
1
Conformité Européenne
Ask AI about this supplier
Curious about this supplier? Ask AI for a quick overview.
Key export market
🇦🇲 Armenia🇦🇲 Armenia
🇺🇦 Ukraine🇺🇦 Ukraine
🇷🇺 Russia🇷🇺 Russia
🇹🇷 Turkey🇹🇷 Turkey
🇺🇸 United States🇺🇸 United States
🇰🇿 Kazakhstan🇰🇿 Kazakhstan
🇮🇳 India🇮🇳 India
🇲🇳 Mongolia🇲🇳 Mongolia
🇰🇷 South Korea🇰🇷 South Korea
🇷🇴 Romania🇷🇴 Romania
🇭🇷 Croatia🇭🇷 Croatia
🇷🇸 Serbia🇷🇸 Serbia
🇧🇦 Bosnia and Herzegovina🇧🇦 Bosnia and Herzegovina
🇨🇭 Switzerland🇨🇭 Switzerland
AsiaAsia
EuropeEurope
North AmericaNorth America
Shipments
Shipments count
0
Export volume
0 kg
Export countries
0
Customers
0
Insights
Top 5 customers
Reflecting the depth of cooperation between supplier and customers
Top 5 customers
This insight is only available in the Pro plan
Top 5 export countries
Reflecting the supplier's export experience in target countries
Top 5 export countries
This insight is only available in the Pro plan
Shipment count distribution
Reflecting the supplier's market business activity
All categories
Loading chart data...
Shipment count distribution
This insight is only available in the Pro plan
Export weight distribution (kg)
Reflecting the supplier's export scale
All categories
Loading chart data...
Export weight distribution (kg)
This insight is only available in the Pro plan
Export weight trend (kg)
Reflecting the growth rate of the supplier's phased total supply volume and the fluctuation of supply volume, identifying supply peaks and troughs
All categories
Loading chart data...
Export weight trend (kg)
This insight is only available in the Pro plan
CIF trend (USD)
For identifying high-value cooperation periods and single order value changes
All categories
Loading chart data...
CIF trend (USD)
This insight is only available in the Pro plan
Similar suppliers you may like
Pymepharco Joint Stock Company
🇻🇳 Vietnam
19891001-2000 peopleManufacturer/Distributor
High capacity factory
Established brand
Large enterprise group
OEM manufacturer
Shipments
668
Key customer
MERIEUX NUTRISCIENCES
Key market
🇻🇳 Vietnam
Description
Pymepharco Joint Stock Company is a leading pharmaceutical manufacturer and distributor based in Tuy Hoa, Vietnam. Established as a subsidiary of the global STADA Group, the company has evolved from a local medical supplier into a major regional player with a workforce of over 1,000 employees. Pymepharco specializes in the production of high-quality generic pharmaceuticals, prescription drugs, and OTC medicines, with a particular focus on antibiotics such as Cephalosporin. Their extensive product portfolio includes analgesics, antipyretics, anti-inflammatory drugs, vitamins, minerals, and dietary supplements, as well as medical equipment and medicinal chemicals.
The company operates advanced manufacturing facilities, including the modern PME II factory, which features a production capacity of 1.2 billion tablets per shift annually. Pymepharco is distinguished as a pioneer in Vietnam for achieving EU-GMP standards, ensuring their injectable powders, tablets, soft and hard capsules, and granules meet international quality benchmarks. In addition to its own branded products, the company provides OEM services and maintains strategic partnerships with international firms like Enzymatica. As a key contributor to the Southeast Asian pharmaceutical supply chain, Pymepharco focuses on delivering affordable, high-quality healthcare solutions through sustainable development and advanced scientific applications.
Pymepharco Building
Mekophar Chemical Pharmaceutical Joint-Stock Company
Mekophar Chemical Pharmaceutical Joint-Stock Company (MEKOPHAR) is a prominent Vietnamese pharmaceutical manufacturer and distributor headquartered in Ho Chi Minh City. Established in 1975 and equitized as a joint-stock company in 2002, the organization has grown into a major industry player with a workforce of approximately 500 to 1,000 employees and an annual revenue estimated at $157.9 million. The company operates multiple production bases and a nationwide distribution network with branches in Hanoi, Da Nang, and Can Tho.
Mekophar specializes in a comprehensive range of healthcare solutions, including the manufacturing, export, and import of pharmaceuticals, herbal medicines, and oriental medicines. Its extensive product portfolio covers therapeutic areas such as antibiotics (oral and injectable), analgesics, antipyretics, cardiovascular drugs, gastrointestinal agents, and antimalarials. Beyond finished dosage forms, the company supplies pharmaceutical raw materials, medical devices, and specialized packaging solutions including plastic bottles and carton boxes.
As a vertically integrated manufacturer, Mekophar offers OEM services and maintains a focus on high-quality standards to serve both domestic and international markets. The company has also diversified its business interests into stem cell banking services through its relationship with Mekostem, as well as food technology and cosmetics. Listed on the UPCOM securities trading center under the ticker MKP, Mekophar remains a key contributor to the regional pharmaceutical sector through its commitment to safe and effective public health products.